Journal article icon

Journal article

Acetazolamide fails to decrease pulmonary artery pressure at high altitude in partially acclimatized humans.

Abstract:

In this randomized, double-blind placebo controlled trial our objectives were to determine if acetazolamide is capable of preventing high altitude pulmonary edema (HAPE) in trekkers traveling between 4250 m (Pheriche)\4350 m (Dingboche) and 5000 m (Lobuje) in Nepal; to determine if acetazolamide decreases pulmonary artery systolic pressures (PASP) at high altitude; and to determine if there is an association with PASP and signs and symptoms of HAPE. Participants received either acetazolamide ...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1089/ham.2007.1073

Authors


Basnyat, B More by this author
Hargrove, J More by this author
Srivastav, S More by this author
Expand authors...
Journal:
High altitude medicine and biology
Volume:
9
Issue:
3
Pages:
209-216
Publication date:
2008
DOI:
EISSN:
1557-8682
ISSN:
1527-0297
URN:
uuid:fd9d7201-b2cc-4761-8410-2b6da9118181
Source identifiers:
186744
Local pid:
pubs:186744

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP